Evidence map›Paper›PMID 33764261›Full record

ArticleThe veterinary quarterly2021

Longitudinal assessment of B-RAF V595E levels in the peripheral cell-free tumor DNA of a 10-year-old spayed female Korean Jindo dog with unresectable metastatic urethral transitional cell carcinoma for monitoring the treatment response to a RAF inhibitor (sorafenib).

Jung-Hyun Kim, Dana Hyunjung Ahn, Je-Sung Moon, Hyun-Jung Han, Kieun Bae, Kyong-Ah Yoon

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The veterinary quarterly, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Expression of MutatedVeterinary sciences · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jung-Hyun KimDepartment of Veterinary Internal Medicine, College of Veterinary Medicine, Konkuk University, Seoul, South Korea.ORCID https://orcid.org/0000-0003-0719-3266
Dana Hyunjung AhnDepartment of Veterinary Internal Medicine, Konkuk University Veterinary Medical Teaching Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0002-2828-7416
Je-Sung MoonVeterinary Emergency Medicine and Critical Care, Konkuk University Veterinary Medical Teaching Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0001-9304-2119
Hyun-Jung HanVeterinary Emergency Medicine and Critical Care, Konkuk University Veterinary Medical Teaching Hospital, Seoul, South Korea.ORCID https://orcid.org/0000-0002-1910-1261
Kieun BaeDepartment of Veterinary Biochemistry, College of Veterinary Medicine, Konkuk University, Seoul, South Korea.ORCID https://orcid.org/0000-0001-6382-446X
Kyong-Ah YoonDepartment of Veterinary Biochemistry, College of Veterinary Medicine, Konkuk University, Seoul, South Korea.ORCID https://orcid.org/0000-0002-9823-7393
Konkuk University · KRVeterinary Medical Teaching Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transitional cell carcinoma (TCC) is the most common malignant tumor of the canine urinary tract. In this case study, a dog with metastatic urethral TCC was treated with sorafenib. The tumor expression levels of receptor tyrosine kinase genes, including

Indexed as

AnimalsAntineoplastic AgentsCarcinoma, Transitional CellCirculating Tumor DNADog DiseasesDogsFemaleLymphatic MetastasisMutationProto-Oncogene Proteins B-rafSorafenibTreatment OutcomeUrethral NeoplasmsAntineoplastic AgentsCirculating Tumor DNAProto-Oncogene Proteins B-rafSorafenibB-RAF V595Ecirculating cell-free tumor DNADogsorafenibtransitional cell carcinomavascular endothelial growth factor

Identifiers

PMID33764261
PMCPMC8118428
OpenAlexW3138498478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.